INTRODUCTION
Doxorubicin is a highly effective cancer chemotherapeutic agent, but its clinical use is severely restricted by its serious cardiotoxicity [see Singal et al. (1987) and Olson & Mushlin (1990) for reviews]. Several mechanisms have been suggested to explain the cardiotoxicity ofdoxorubicin, yet no single hypothesis adequately describes the observed cardiotoxic actions of the drug. One theory is an intercalation of the drug between basepairs of DNA helices, with subsequent inhibition of DNA replication and RNA synthesis (DiMarco, 1975) . Generally, no correlation is observed between antitumour potency and intercalative affinity, because various potent intercalators lack antitumour properties (Johnson et al., 1979; Kapuscinski & Darynkiewicz, 1986) . In addition, an analogue ofdoxorubicin, Ntrifluoroacetyladriamycin 14-valerate, is an active antitumour agent, but does not enter the nucleus or bind DNA (Krishan et al., 1976) . However, Ito et al. (1990) have shown an early onset of selective inhibition of cardiac myofibril gene expression by doxorubicin. Another hypothesis proposed to explain doxorubicin cardiotoxicity is the intracellular-Ca2+-overload hypothesis (Olson & Mushlin, 1990) . Treatment of rabbits with doxorubicin showed the formation of Ca2+ inclusions in mitochondria of ventricular myocardium (Olson et al., 1974) . However, papillary muscles of rabbits treated with doxorubicin showed a decreased contractility, suggestive of low cytoplasmic Ca2+ (Jensen, 1986) . Over the years the free-radical hypothesis for doxorubicin-induced cell damage has received considerable attention (Powis, 1989) . Doxorubicin is believed to generate toxic oxygen radicals by way of oxidation-reduction cycling. Nonetheless, many observations appear inconsistent with this free-radical hypothesis [see Olson & Mushlin (1990) (Chacon & Acosta, 1991) . These data suggested that the release of superoxide radical anions from mitochondria may be the result of altered mitochondrial Ca2+ cycling.
The main objective of the present study was to investigate further the role of mitochondrial Ca2' in doxorubicin-induced cardiotoxicity. Employing the use of digitized fluorescence imaging (DFI) and the Ca2+-sensitive dye fura-2, we estimated cytosolic and mitochondrial Ca2+ in cultured myocardial cells treated with doxorubicin. We show here that mitochondrial Ca2+ overload is an early event in the onset of doxorubicin-induced cell damage and relate these changes to a dissipation in mitochondrial membrane potential and a decline in cellular ATP, both of which precede a rise in cytosolic Ca2+.
EXPERIMENTAL

Materials
Fura-2 acetoxymethyl ester (fura-2 AM), was purchased from Molecular Probes (Eugene, OR, U.S.A.). Rhodamine 123 (rh-123) was purchased from Eastman Kodak. Ruthenium Red, diltiazem, digitonin, 2,4-dinitrophenol (DNP) and imidazole (99 % purity) were purchased from Sigma Chemical Co. Doxorubicin was purchased from Adria as a sterilized Adriamycin PFS (1 mg/ml) solution. All other reagents were of the highest available purity from commercially obtainable sources.
Myocardial-celi cultures
Primary myocardial cell cultures were prepared as previously described (Mbuga et al., 1988) (Wenzel et al., 1970) . After 3 h, the resultant myocyte supernatant was poured off, and either 0.5 ml aliquots were plated on 25 mm-diameter round glass coverslips for imaging studies or 3 ml were used to plate 35 mm culture dishes for ATP experiments. The myocyte cultures were maintained in Eagle's minimum essential medium (EMEM) supplemented with 5 % newborn-calf serum and antibiotics [penicillin G potassium salt (0.5 units/ml), streptomycin sulphate (0.05 mg/ml) and amphotericin B (0.5 ,g/ml)]. The cells were grown in a humidified atmosphere (37°C) of C02/air (1:19) to maintain a pH of 7.2-7.4. The medium was replaced 24 h before the day of the experiments.
Drug treatments
Experiments were conducted 4 days after the initial plating of the myocytes. Myocardial-cell cultures were treated with 50 /Mdoxorubicin in order to compare the effects of doxorubicin on intracellular Ca2+ with our previous studies (Chacon & Acosta, 1991) . The doxorubicin drug treatments were made by diluting aliquots of the 1 mg/ml Adriamycin PFS solution.
DFI
We have tried to include a detailed description of the instrumentation procedures throughout the experimental section, since the present paper is one of the first to report the use of a Photon Technology International (PTI-IMAGESCAN system. DFI was performed using a PTI-IMAGESCAN system attached to a Zeiss IM-35 epifluorescence microscope. The illumination unit consisted of a 75 W xenon arc lamp whose illumination path first encounters a rotating chopper disc that can alternately reflect or transmit the beam through one of two monochromators. The monochromator outputs (excitation source) are combined into a bifurcated optical fibre and conducted to an epifluorescence microscope. A Hamamatsu silicon-intensified-target camera detects the low-level fluorescence, amplifies the signal and directs the signal to the video workstation. The video workstation (80386-based microcomputer) accepts and digitizes the analog signal for subsequent analysis and resulting digital images. The actual video processing is done by two specialized boards within the computer. Video images from the camera are transported to the computer through a video-input-system board and relayed to the monitor through the video-output-system board. Image processing immediately occurs in 16-bit arithmetic logic units and/or in an array of Look Up Tables. The video-output-system 'board contains its own Look Up Tables, frame memory and red/green/blue display interface. Therefore ratioed images can be viewed in almost real time.
For fluorescent-intensity values of single-excitation/singleemission probes such as rhodamine-123, thresholding was applied to remove all information at less than a specified cut-off level. However, with ratioed images of dual-excitation/single-emission compounds such as fura-2, background suppression utilized a more sophisticated technique known as intensity-weighted ratio presentation. This technique was developed by Lipscombe and co-workers (Lipscombe et al., 1988; Tsien & Harootunian, 1990) . Inmost digital-imaging systems a pseudocolour is assigned to a ratioed value obtained by dividing the intensity signals received from the alternating wavelengths. However, a problem arises where the numerator and denominator of the intensity ratio are both nearly zero, as is the case between cells. The most common technique is to set a threshold value where low intensities are cut off. Unfortunately, such thresholding may suppress important features if set too high. PTI-IMAGESCAN software incorporates an intensity-weighted ratio presentation. In essence, this background-suppression technique forms a ratioed image in which each pixel value encodes not only its ratio value but also a weighting parameter specifying the mean intensity of the signal. Hence the higher the mean intensity, the more significant the data are likely to be and the more brightly the image is displayed with complete background suppression. An intensity-weighted ratio presentation allows one to judge the spatial thickness of a cell as well as dye accumulation in localized regions within a cell.
Selective compartmental localization of fura-2 Acetoxymethyl ester fluorescent probes loaded into cells may localize into cellular compartments (Davis et al., 1987; Steinberg et al., 1987; Gores et al., 1989) . Compartmental localization can be viewed after selective permeabilization of the plasma membrane to release the cytosolic contents. We determined the loading conditions in our cardiac cells that were required to load fura-2 into both the cytosolic and mitochondrial compartments. Cytosolic fura-2 loading was accomplished by incubating the myocytes with1IFM fura-2 acetoxymethyl ester (AM) for 30 min at 25 'C. Mitochondrial localization of fura-2 was evaluated by a modified procedure of Gores et al. (1989) . Briefly, myocytes grown on glass coverslips were co-loaded with 2.5 FM-fura-2 AM and 1 uM-rh-123 for 1 h at 37 'C in culture medium (EMEM) supplemented with 2.5 % (v/v) newborn-calf serum. After loading, the cells were washed three times with a respiratory Krebs-Ringer-Henseleit medium buffered to pH 7.4 with imidazole (R-KRHI; 110 mM-NaCI/5 mM-KCl/1 mM-MgSO4/ 1.25 mM-CaCl2/8 mM-NaHCO3/0.5 mM-Na2HPO4/0.5 mm-KH2PO4/ 10 mM-glucose/15 mM-imidazole/ 1.3 mM-malate/ 5 mM-glutamate/5 mm-succinate). After washing, the cells were mounted in a microscope-stage incubation chamber for subsequent analysis by DFI. Single-excitation intensity-emission images of either fura-2 or rh-123 were captured using the appropriate excitation wavelength and emission filters. The Ca2+-sensitive wavelength of fura-2 was chosen (monochromator 1 was set at 350 nm) for imaging the spatial distribution of Ca2+ probe. Rh-123 was excited by using monochromator 2 set at 470 nm. The fura-2 excitation wavelength was reflected to the sample by a 400 nm dichroic long-pass filter. A 490-530 nm band-pass filter was used to select the fura-2 emission signal. The rh-123 excitation source was reflected by a 510 dichroic long-pass filter, whereas the emission signal was selected using a 520 nm long-pass filter. After acquiring intensity images representing each probe, the plasma membrane was selectively permeabilized with a 25,uM-digitonin solution containing 5 mM-EGTA, 1I MRuthenium Red and 350 FM-diltiazem (added as a 1:1 dilution from a twice-concentrated stock solution). After cell lysis (4 min) intensity images were again recorded for each probe. The mitochondrial membrane potential was dissipated using 200 ZM-DNP, and intensity images were recorded after 4 min. DFI of cytosolic Ca2+ content using fura-2 Cytosolic Ca2+ was estimated by using fura-2 AM. Intracellular esterases hydrolyse the acetoxymethyl ester bonds and release the cell-impermeant free fura-2 into the cytosol. Fura-2 exhibits a Ca2+-dependent fluorescence (350 nm excitation) and a Ca2+_ independent fluorescence (380 nm excitation) (Grynkiewicz et al., 1985) . Cardiac myocytes grown on glass coverslips in 2 ml of MEM were loaded with 1 M fura-2 AM dissolved in dimethyl sulphoxide (DMSO) (5 Fl of DMSO/2 ml of MEM). The cells were incubated with fura-2 AM for 30 min at 25 IC. Drugtreated myocytes were incubated with 50,uM-doxorubicin at 37 'C in MEM containing 2.5 % newborn-calf serum. After 3, 6, and 10 h of doxorubicin exposure, the myocytes were loaded with fura-2 AM. The cells were washed three times with R-KRHI buffer, placed in the chamber and analysed by DFI at room temperature to inhibit beating. Using the average of four frames for each wavelength, we used ratioed images (350 nm/380 nm) to determine the cytosolic free Ca2 . Control myocytes (non-drug-treated cells) loaded with fura-2 were used to adjust the slit widths of the excitation monochromators such DFI images selective for fura-2 (A, B and C) were recorded using 350 nm excitation, whereas selective rh-123 images D, E and F were recorded using 470 nm excitation. The respective emission filters are described in the Experimental section. Images A and D represent intact cells, whereas images B and E were recorded after selective permeabilization of the plasma membrane with 25 /SM-digitonin. Images C and F were recorded after the addition of the uncoupler 2,4-DNP.
that the ratio was set to 1 in order to minimize the dynamic range in which the camera must work (Tsien & Harootunian, 1990) . The adjustment was made under an intensity-display format of both the 350 nm and 380 nm signals and using the video-adjust colour-map display to adjust the sensitivity of the camera. The slit widths were adjusted such that the intensity from both the 350 and 380 signals were equal. The sensitivity of the camera gain was adjusted such that little to no flecks of red appear, which represented the high end of the camera. The low end of the camera (offset) was set before adjusting the sensitivity by closing off any light to the camera and adjusting the offset such that a 50/50 mixture of blue and black was being displayed on the colour monitor. If the histogram mode was activated, for the low-end adjustment, we tried to ensure that half of the intensity histogram peak was below the detection limits of the camera (i.e. a 50:50 mixture of the signal should be on and off scale). Final slit widths were 2 and 1.5 nm for monochromators 1 and 2, corresponding to the excitation wavelengths 350 and 380 nm respectively. Alternating excitation wavelengths were reflected to the sample by a 400 nm dichroic long-pass filter. A 490-530 nm band-pass filter was used to select the fura-2 emission signal. Autofluorescence in the presence or absence of doxorubicin at either 350 or 380 nm excitation did not interfere with the total emission signal.
DFI of total cellular Ca2+
Total cellular Ca2+ was estimated using fura-2 AM and cardiac myocytes grown on glass coverslips. After 0, 3, 6 and 10 h of doxorubicin exposure, myocytes were loaded with 2.5,tM-fura-2 AM for 1 h at 37 'C. After loading, cells were washed three times with R-KRHI buffer and mounted in a chamber for subsequent analysis by DFI as described above.
DFI of mitochondrial membrane potential Mitochondrial membrane potential in intact myocytes was estimated using rh-123 (Chen, 1988) and myocytes grown on glass coverslips as described above. After 0, 3, 6 and 10 h of doxorubicin exposure, the myocytes were loaded with 1 IM-rh-123 for 1 h at 37 'C. The cells were then washed three times with R-KRHI buffer and mounted in a chamber for subsequent DFI. Rh-123 was excited at 470 nm. A 510 nm dichroic long-pass filter was used to reflect the excitation wavelength to the sample, whereas a 520 nm long-pass filter was used to help select the emission wavelength. In addition, a 490-530 nm band-pass filter was placed after the 520 nm long-pass emission filter to reduce further the fluorescent emission from doxorubicin (550-625 nm) and increase the selective emission of rh-123 (525 nm).
Measurement of cellular ATP
Cellular ATP content was determined by h.p.l.c. on cell extracts taken from cell monolayers which had been plated in 35 mm dishes. After appropriate treatments, the cell monolayers were rinsed twice with ice-cold 0.1 M-potassium phosphate buffer, pH 7.4, and placed on ice. An aliquot of ice-cold 0.1 M-HCO04
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(1 ml) was added to each dish to extract the ATP. The monolayers were scraped off and collected in 2 ml centrifuge vials. The solution was adjusted to pH 5 with 1.0 M-KOH (0.5 ml) dissolved in mobile phase, at which time a white precipitate of KC04
formed. The resultant suspension was centrifuged at 11000 g for 1 min. (Bailey, 1967) .
RESULTS AND DISCUSSION
Recently we reported that the production of intracellular reactive oxygen species by doxorubicin may result from changes in mitochondrial calcium homoeostasis (as measured by indirect techniques) (Chacon & Acosta, 1991) . Thus the purpose of the present study was to evaluate the direct effects of doxorubicin on mitochondrial Ca2+. To estimate mitochondrial Ca2+, we took advantage of fura-2's ability to localize within the mitochondria of fura-2-loaded cells. By dual-loading the myocytes with fura-2 and rh-123, we could selectively image the intensity-emission signals from either probe. For fura-2 emission intensities, we chose the Ca2+-sensitive excitation wavelength of 350 nm. Fura-2 displays a diffuse labelling of the cytosol (Fig. 1, image A) , whereas rh-123 shows a selective localization of the dye to the mitochondria (Fig. 1, image D) . After selective permeabilization of the plasma membrane with 25 ,uM-digitonin (Fig. 1, images B and E) we found that both images (fura-2 and rh-123 respectively) were essentially superimposable. Our permeabilizing experiments with digitonin, as shown in Fig. 1 , images B and E, included the incorporation of EGTA to chelate Ca21 present in the incubation buffer and the addition of malate, glutamate, and succinate to provide essential respiratory substrates. The exclusion of these additives resulted in a collapse of the mitochondrial membrane potential immediately upon permeabilization of the plasma membrane (results not shown).
To release both Ca2+ and rh-123 from the mitochondria, we added the protonophore DNP to collapse the mitochondrial membrane potential (Fig. 1 , images C and F respectively). These data support mitochondrial localization of fura-2.
Loading conditions (1 /SM-fura-2 AM for 30 min at 25°C)
were determined to keep the majority of the fura-2 within the cytosolic compartment (Fig. 2, image A) . After permeabilization of the plasma membrane with digitonin (Fig. 2, image B) , we found that the majority of the fura-2 signal was lost, suggesting that the fura-2 was localized mainly to the cytosolic compartment.
When the myocytes were incubated with 2.5 /uM-fura-2 AM for 1 h at 37 OC (Fig. 2 , image C), we found that, after permeabilization of the plasma membrane, some of the fura-2 had sequestered within the mitochondria (Fig. 2, image D) . We added Ruthenium Red, a mitochondrial Ca2+-uptake blocker (Nichols & Akerman, 1982) , and diltiazem, an inhibitor of mitochondrial Ca2+ release (Rizzuto et al., 1987) , to the permeabilizing solution to inhibit mitochondrial Ca2+ uptake and release, thus minimizing mitochondrial Ca2+ artefacts upon permeabilization. Therefore Fig. 2 , image D, represents mitochondrial Ca2+ (Fig. 2 , image C, total cellular Ca2+; Fig. 2 , image A, cytosolic Ca2+). Cytosolic free Ca2+ in our myocardial-cell preparation was essentially unaffected after 3-6 h of 50 ,uM-doxorubicin (Fig. 3) in 100% of the cells examined (Table 1) . A greater-than-2-fold increase in cytosolic free Ca2+ was observed in 12 % of the cells examined after 10 h of exposure to 50 ,uzM-doxorubicin. This rise in Ca2+ paralleled the release of the cytosolic marker enzyme lactate dehydrogenase, which was detectable after 12 h (Chacon & Acosta, 1991) . Considering that the cells were loaded with fura-2 AM for 30 min after a 10 h exposure to doxorubicin, one cannot rule out the possibility that some of the cells in Fig. 3 , image D, represent cells with leaky plasma membranes. Control cells (100 %) showed a ratio of approx. 1.0 for total cellular Ca21 (Fig. 4, image A) . Permeabilization of the control cells with digitonin revealed that 98 % of the mitochondria also retained a ratio of 1.0 for Ca2+ (Fig. 4, image B) . After 3 h of doxorubicin treatment, 85 % of the myocytes showed a ratio of 1 for total cellular Ca2+ (Fig. 4, image C) . Permeabilization showed that 14 % of the mitochondria exhibited a greater-than-2-fold increase in Ca2+ (Fig. 4, image D) . After 6 h ofdoxorubicin treatment, 23 % of the cells exhibited greater-than-2-fold increases in total cellular Ca2+, and with 50% of their mitochondria also showing greater-than-2-fold increases (Fig. 4 , images E and F respectively). After 10 h of doxorubicin treatment, 53 % of the cells showed greater-than-2-fold increases in total cellular Ca2+ and with 66% of their mitochondria demonstrating Ca2+ ratios greater than 2.0 (Fig. 4 , images G and H respectively). Interestingly, we observed some cells that experienced greater-than-2-fold increases in mitochondrial Ca2+ (Fig. 4 , image E), whereas total cellular Ca2+ remained similar to controls (Fig. 4 , image C versus image A). In Fig. 4, images D and F, the intensity-weighted ratio presentation did not indicate the mitochondrial fraction of the respective cells shown in Fig.  4 , images C and E, to be higher than a ratio of 1. An explanation (Fig. 3 , images B and C) and that mitochondrial Ca2+ may increase 2-fold (Fig. 4 , images D and F). These data suggest that the mitochondria may be involved in buffering cytoplasmic c2+.
Ca2
The doxorubicin-induced time-dependent increase in mitochondrial Ca2+ at both the 3 and 6 h time points (Table 1) paralleled the intracellular production of reactive oxygen species (Chacon & Acosta, 1991) . We had postulated that the doxorubicin-induced formation of superoxide radical anions might be due to a cycling of mitochondrial Ca2 . Concomitant with the energy-dependent uptake of Ca2+ is the electroneutral release of Ca2+ that provides a continuous cycling of the cation across the mitochondrial inner membrane (Crompton, 1985) . Because doxorubicin may cause mitochondrial Ca2+ accumulation (Singal et al., 1987) and at the same time an inability to sequester accumulated calcium (Sokolove & Shinaberry, 1988) , it is conceivable that the observed increases in mitochondrial calcium. Fig. 4 , images D, F and H, may indirectly represent mitochondrial Ca2+ cycling.
Mitochondrial Ca2+ accumulation is a process made energetically possible by either respiratory substrate oxidation or ATP hydrolysis (Scarpa, 1979; Gunter & Pfeiffer, 1990) . Hence, Ca2+ transport driven by either respiration or ATP hydrolysis occurs at the expense of a common pool of energy maintained by the electrochemical proton gradient. Thus futile mitochondrial Ca2+ cycling would result in a dissipation in the mitochondrial membrane potential. DFI of rh-123, a specific fluorescent probe used to label and monitor mitochondrial membrane potential (Chen, 1988) , served as a measure of the relative mitochondrial membrane potential in cardiac cells exposed to doxorubicin. Chemical agents that dissipate the mitochondrial membrane potential, such as 2,4-DNP, prevent rh-123 uptake (Chen, 1988) . Fig. 5 shows intensity images of rh-123 and the time-dependent collapse of the mitochondrial membrane potential in cardiac cells exposed to 50juM-doxorubicin. Fig. 5 , image A, illustrates a group of control myocytes with regions of intense staining by rh-123. Decreased rh-123 fluorescence was observed in myocytes exposed to 50 ,sM-doxorubicin for 3 h (Fig. 5, (Chacon & Acosta, 1990) and presented herein, is that doxorubicin produces an increase in mitochondrial Ca2+ that is associated with the production of reactive oxygen species and a dissipation in the mitochondrial membrane potential. In addition, doxorubicininduced mitochondrial dysfunction may result in a depletion in cellular ATP. Previous reports have indicated that mitochondrial Ca2l overload may be a mechanism for cellular injury by doxorubicin (Olson et al., 1974) . On the other hand, reports by Jensen (1986) 
